Stocks and Dollars

VFC submits:

CryptoLogic Limited (CRYP) is once again trading for roughly three dollars after trading for over seven bucks just five months ago. This company that brands and licenses online betting software and games is still a recovery story and is once again a nice buy – in my opinion.

Quarterly numbers for CryptoLogic have come in below expectations during the global economic downturn – due to the fact that potential gamblers are not willing to spend quite so much, and also due to the fact that the licensee companies have been crunched by the economy. However, as the global economy normalizes and CryptoLogic continues to license its brands, I think CRYP could be a good bet to at least double for the mid term.

Complete Story »

The 451 Group: Inorganic Growth submits:

By Brenon Daly

Apparently, UPEK really wants to be a public company. It put in its IPO paperwork back in mid-2007, only to pull it in March 2008. Unlike other former filers, however, the biometric security vendor hasn’t dusted off its S-1 in an attempt to hit the public markets. (In the past week, both Convio and GlassHouse Technologies have re-filed to go public.) Instead, UPEK wants to get on the Nasdaq by picking up a rival that already trades there.

Complete Story »

Jim Trippon submits:

The newswires are buzzing about China’s growth curve once again. This time there’s intense debate about the meaning of the latest manufacturing data. Is it up? Or is it down?

Complete Story »

Thomas MacLeod submits:

We have always maintained that the best way to understand the mood of any stock market is to look at the behaviour of small caps. Small caps have a wonderful tendency to trend with relatively little volatility which makes depicting the true trend of the market considerably easier. Furthermore, due to their relative lack of liquidity their action forewarns or leads the behaviour of large cap indices.

We would like to draw your attention to one of the hottest equity markets in the world, Moscow. Look at the behaviour of the MICEX Small Cap index. It is at a multi-week high and gives every indication that it wants to move higher. Of course it is somewhat difficult to invest in Russian small caps themselves but for the average investor the ETF RSX will suffice.

Complete Story »

VFC submits:

LaboPharm, Inc. (DDSS) announced on Wednesday that the US FDA has approved OLEPTRO, the company’s treatment for major depressive disorder [MDD] in adults. OLEPTRO is a once-daily formulation of trazodone and utilizes the LaboPharm’s controlled release technology, CONTRAMID.

According to the Wednesday morning press release, the company expects to have OLEPTRO available for prescription in the United States later this year.

Complete Story »